These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3303891)

  • 1. Effect of one year of thiazide therapy on plasma volume, renin, aldosterone, lipids and urinary metanephrines in systolic hypertension of elderly patients.
    Vardan S; Dunsky MH; Hill NE; Mehrotra KG; Mookherjee S; Smulyan H; Warner RA
    Am J Cardiol; 1987 Aug; 60(4):388-90. PubMed ID: 3303891
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic systolic hypertension in the elderly: correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy.
    Vardan S; Dunsky MH; Hill NE; Mookherjee S; Smulyan H; Warner RA
    Am J Cardiol; 1986 Nov; 58(10):1030-4. PubMed ID: 3535470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamics during long-term thiazide treatment in essential hypertension: differences between responders and non-responders.
    Van Brummelen P; Man in't Veld A; Schalekamp MA
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():359s-362s. PubMed ID: 396081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body fluid volumes and the response of renin and aldosterone to short- and long-term thiazide therapy of essential hypertension.
    van Brummelen P; Schalekamp MA
    Acta Med Scand; 1980; 207(4):259-64. PubMed ID: 6992515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazide induced hypotension: the role of plasma volume reduction and the urinary kallikrein system.
    Solomon RJ; Stillman N; Weinberg MS
    Adv Exp Med Biol; 1986; 198 Pt B():243-51. PubMed ID: 3544727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders.
    van Brummelen P; Man in 't Veld AJ; Schalekamp MA
    Clin Pharmacol Ther; 1980 Mar; 27(3):328-36. PubMed ID: 6987024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between renin and aldosterone during chronic diuretic therapy. Effect of the addition of a beta blocker, timolol.
    Lebel M; Grose JH; Belleau LJ
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):424-7. PubMed ID: 489761
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of renin, aldosterone, electrolytes and extracellular spaces during combination diuretic therapy in hypertensive patients].
    Hilfenhaus M; Erbler HC; Mariss P; Liebau H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():299-302. PubMed ID: 611970
    [No Abstract]   [Full Text] [Related]  

  • 12. Volume-dependent essential and steroid hypertension.
    Dustan HP; Bravo EL; Tarazi RC
    Am J Cardiol; 1973 May; 31(5):606-15. PubMed ID: 4698131
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension.
    Lijnen P; Fagard R; Staessen J; Amery A
    Br J Clin Pharmacol; 1981 Sep; 12(3):387-92. PubMed ID: 7028060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of long-term hydrochlorothiazide treatment on blood pressure and plasma volume in patients with normal and low-renin arterial hypertension].
    Wyrzykowski B
    Wiad Lek; 1986 Oct; 39(19):1297-303. PubMed ID: 3551335
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal responses to antihypertensive treatment with captopril or hydrochlorothiazide.
    Rabinad E; Gaya J; Rivera F; Ingelmo M; Balcells A
    Postgrad Med J; 1986; 62 Suppl 1():143-5. PubMed ID: 3534850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.